238 related articles for article (PubMed ID: 31301589)
21. Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship?
Attilakos A; Garoufi A; Voudris K; Mastroyianni S; Fotinou A; Papadimitriou DT; Gavalakis N; Prassouli A; Katsarou E
Eur J Paediatr Neurol; 2007 Nov; 11(6):358-61. PubMed ID: 17428707
[TBL] [Abstract][Full Text] [Related]
22. Relationship between bone density and levetiracetam monotherapy in epilepsy patients.
Gözükızıl ST; Aydın Z; Yalçın AD
Clin Neurol Neurosurg; 2022 Jul; 218():107270. PubMed ID: 35623138
[TBL] [Abstract][Full Text] [Related]
23. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes.
Suo GH; Zheng YQ; Wu YJ; Tang JH
Acta Neurol Belg; 2021 Oct; 121(5):1265-1273. PubMed ID: 33590471
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy.
Durá-Travé T; Gallinas-Victoriano F; Malumbres-Chacón M; Moreno-Gónzalez P; Aguilera-Albesa S; Yoldi-Petri ME
Epilepsy Res; 2018 Jan; 139():80-84. PubMed ID: 29197669
[TBL] [Abstract][Full Text] [Related]
25. Impact of enzyme-inducing anti-epilepsy drugs on lipid levels in elderly patients with epilepsy.
Okada S; Nishina M; Koizumi K; Katayama M; Inoue S; Suga S
Epilepsy Res; 2020 Oct; 166():106428. PubMed ID: 32702537
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
Kanemura H; Sano F; Ohyama T; Aihara M
Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
[TBL] [Abstract][Full Text] [Related]
27. Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial.
Elger CE; Rademacher M; Brandt C; Elmoufti S; Dedeken P; Eckhardt K; Tennigkeit F; De Backer M
Epilepsy Behav; 2016 Sep; 62():1-5. PubMed ID: 27423106
[TBL] [Abstract][Full Text] [Related]
28. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K
Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755
[TBL] [Abstract][Full Text] [Related]
29. Levetiracetam monotherapy for elderly patients with epilepsy.
Alsaadi TM; Koopmans S; Apperson M; Farias S
Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With Epilepsy.
Mazur RD; Wang Ba Q; Kato Bs K; Buchsbaum Bs R; Bonito Bs J; Choi H; Hirsch L; Detyniecki K
J Child Neurol; 2019 Sep; 34(10):593-597. PubMed ID: 31113283
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
Cardona AF; Rojas L; Wills B; Bernal L; Ruiz-Patiño A; Arrieta O; Hakim EJ; Hakim F; Mejía JA; Useche N; Bermúdez S; Carranza H; Vargas C; Otero J; Mayor LC; Ortíz LD; Franco S; Ortíz C; Gil-Gil M; Balaña C; Zatarain-Barrón ZL
J Neurooncol; 2018 Jan; 136(2):363-371. PubMed ID: 29177594
[TBL] [Abstract][Full Text] [Related]
32. [Follow-up study on levetiracetam monotherapy in children with epilepsy].
Gao ZJ; Jiang YW
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):711-4. PubMed ID: 19102836
[TBL] [Abstract][Full Text] [Related]
33. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
35. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes.
Sonmez FM; Demir E; Orem A; Yildirmis S; Orhan F; Aslan A; Topbas M
J Child Neurol; 2006 Jan; 21(1):70-4. PubMed ID: 16551457
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
Ballvé A; Salas-Puig J; Quintana M; Campos D; Llauradó A; Raspall M; Fonseca E; Abraira L; Santamarina E; Toledo M
Acta Neurol Scand; 2021 Apr; 143(4):407-412. PubMed ID: 33452703
[TBL] [Abstract][Full Text] [Related]
37. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
Svalheim S; Luef G; Rauchenzauner M; Mørkrid L; Gjerstad L; Taubøll E
Acta Neurol Scand Suppl; 2010; (190):30-3. PubMed ID: 20586732
[TBL] [Abstract][Full Text] [Related]
39. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
